Inari Medical, Inc. Share Price

Equities

NARI

US45332Y1091

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:02 31/05/2024 BST 5-day change 1st Jan Change
50 USD -1.37% Intraday chart for Inari Medical, Inc. +0.09% -22.99%
Sales 2024 * 599M 47.01B Sales 2025 * 705M 55.4B Capitalization 2.91B 228B
Net income 2024 * -49M -3.85B Net income 2025 * 8M 628M EV / Sales 2024 * 4.72 x
Net cash position 2024 * 80.82M 6.35B Net cash position 2025 * 115M 9.03B EV / Sales 2025 * 3.96 x
P/E ratio 2024 *
-54.7 x
P/E ratio 2025 *
353 x
Employees 1,300
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.5%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.37%
1 week+0.09%
Current month-0.01%
1 month+20.18%
3 months+10.12%
6 months-18.31%
Current year-22.99%
More quotes
1 week
49.04
Extreme 49.04
52.10
1 month
41.07
Extreme 41.07
52.10
Current year
36.73
Extreme 36.73
66.35
1 year
36.73
Extreme 36.73
71.85
3 years
36.73
Extreme 36.73
100.00
5 years
36.73
Extreme 36.73
127.42
10 years
36.73
Extreme 36.73
127.42
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 31/08/17
Director of Finance/CFO 65 28/02/19
Chief Tech/Sci/R&D Officer - 31/03/19
Members of the board TitleAgeSince
Director/Board Member 64 31/08/11
Chairman 70 31/08/11
Director/Board Member 57 31/10/19
More insiders
Date Price Change Volume
31/05/24 50 -1.36% 716,890
30/05/24 50.69 +1.54% 751,446
29/05/24 49.92 -0.64% 611,178
28/05/24 50.24 +0.58% 1,592,150
24/05/24 49.95 +5.29% 1,144,226

Delayed Quote Nasdaq, May 31, 2024 at 09:00 pm

More quotes
Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
50 USD
Average target price
64.4 USD
Spread / Average Target
+28.80%
Consensus